Year archive

JW (Cayman) Therapeutics Co. Ltd — 2025 filings

All 48 regulatory filings released by JW (Cayman) Therapeutics Co. Ltd (2126) in 2025, sourced directly from the official regulator.

48 Filings

2025 Period

2025 filings (48)

Filing	Released	Lang
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-12-29	English
CONTINUING CONNECTED TRANSACTION IN RELATION TO EXTENSION OF TERM OF VECTOR SUPPLY AGREEMENT Regulatory Filings	2025-12-22	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-12-12	English
(1) APPOINTMENT OF CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR; (2) APPOINTMENT OF CHAIRMAN OF THE BOARD; (3) RESIGNATION OF CHIEF EXECUTIVE OFFICER, CHAIRMAN AND EXECUTIVE DIRECTOR; Board/Management Information	2025-12-12	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - PRESENTATION OF JWCAR201 IIT STUDY DATA AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING Regulatory Filings	2025-12-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-05	English
MAJOR TRANSACTION IN RELATION TO AMENDMENT NO. 1 TO THE COLLABORATION AGREEMENT Regulatory Filings	2025-10-30	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - DATA SUBMITTED FROM PHASE I STUDY OF RELMA-CEL IN CHINESE ADULT PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS TO NMPA Regulatory Filings	2025-10-21	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - NATIONAL MEDICAL PRODUCTS ADMINISTRATION OFFICIALLY ACCEPTED THE POST-MARKETING SUPPLEMENTAL APPLICATION FOR CARTEYVA, WHICH USES AN IN-HOUSE Regulatory Filings	2025-10-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Share Issue/Capital Change	2025-10-08	English
DELAY IN DESPATCH OF CIRCULAR Report Publication Announcement	2025-09-30	English
2025 INTERIM REPORT Interim / Quarterly Report H2 2025	2025-09-25	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2025-09-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-04	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND CHANGE IN USE OF NET PROCEEDS FROM LISTING Interim / Quarterly Report H2 2025	2025-08-27	English
NOTICE OF BOARD MEETING Report Publication Announcement	2025-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Share Issue/Capital Change	2025-07-07	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 26, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Share Issue/Capital Change	2025-06-05	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON JUNE 3, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-03	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE NMPA ACCEPTANCE OF THE SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION FOR CARTEYVA AS SECOND-LINE TREATMENT IN RELAPSED OR REFRACTORY LARGE B-CELL Regulatory Filings	2025-05-28	English
Documents on Display Regulatory Filings	2025-05-15	English
Form of proxy for the Extraordinary General Meeting to be held on June 3, 2025 Proxy Solicitation & Information Statement	2025-05-15	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-15	English
CONNECTED TRANSACTION IN RELATION TO LICENSE AGREEMENT Proxy Solicitation & Information Statement	2025-05-15	English
CLOSURE OF REGISTER OF MEMBERS Declaration of Voting Results & Voting Rights Announcements	2025-05-14	English
Form of proxy for the Annual General Meeting to be held on June 26, 2025 Proxy Solicitation & Information Statement	2025-05-08	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-08	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES, TRANSFER SHARES OUT OF TREASURY AND REPURCHASE SHARES AND RE-ELECTION OF DIRECTORS AND RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-07	English
2024 Environmental, Social and Governance Report Environmental & Social Information	2025-04-28	English
2024 ANNUAL REPORT Annual Report FY 2024	2025-04-28	English
CONNECTED TRANSACTION IN RELATION TO THE LICENSE AGREEMENT AND FURTHER INFORMATION RELATING TO THE MATERIAL TRANSFER AGREEMENT Regulatory Filings	2025-04-22	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2025-04-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Share Issue/Capital Change	2025-04-03	English
Next Day Disclosure Return Share Issue/Capital Change	2025-04-02	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 Earnings Release FY 2024	2025-03-27	English
CONNECTED TRANSACTION IN RELATION TO MATERIAL TRANSFER AGREEMENT Regulatory Filings	2025-03-19	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-03-17	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-03-14	English
CHANGE OF CHAIRMAN Board/Management Information	2025-03-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-06	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR CARTEYVA IN CHINA AS SECOND-LINE TREATMENT IN RELAPSED OR REFRACTORY ADULT LARGE B-CELL LYMPHOM Regulatory Filings	2025-01-10	English
GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS Share Issue/Capital Change	2025-01-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-06	English